An official website of the United States government
Home
Name
FOLFOXIRI
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for FOLFOXIRI
Name
Alternate Names
5-Fluorouracil
5-Fluracil
Adrucil
Efudex
Fluoroplex
Fluracil
Fluril
Oracil
Ro 2-9757
WR-69596
Abbreviations
5-FU
5FU
FU
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
019893
19893
Primary Site
Breast- adjuvant setting and advanced disease
colorectal- adjuvant setting and advanced disease
GI malignancies: anal, esophageal, gastric and pancreatic
Hepatoma
Ovarian cancer
Histology
None
Remarks
Fluorinated pyrimidine; antimetabolite. FDA approved uses on basal cell carcinoma, breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer.
Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.
Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.
Coding
This drug should be coded
Name
Alternate Names
1-OHP
1670 RBl Eloxatin
Eloxatin
L-OHP
Oxalatoplatin
Oxalatoplatinum
PR-54780
RP-54780
Transplatin
Abbreviations
None
Category
Chemotherapy
Subcategory
Platinum analog
NSC Number
266046
Primary Site
Histology
None
Remarks
A platinum-containing antineoplastic that is usually given in combiantion with 5-FU.
Coding
This drug should be coded
Name
Alternate Names
Camptosar
Camptosar Oral
Camptothecin-11
CPT 11
CPT-11
CPT11
U-101440E
Abbreviations
None
Category
Chemotherapy
Subcategory
Topoisomerase inhibitor
NSC Number
616348
Primary Site
Colorectal
head & neck
Non-small cell lung cancer (NSCLC)
pancreatic cancer
Small cell lung cancer (SCLC)
Histology
None
Remarks
Phase I (head & neck) Phase III SCLC pancreatic Topoisomerase I inhibitor. FDA approved use on colorectal cancer. Pharmacia.
Coding
This drug should be coded
